KRAS and colorectal cancer: Furthermore, the importance of DpR in predicting PPS was reported in KRAS wild-type colorectal cancer patients treated with cetuximab-based chemotherapy [11], implying that this notion can be applied to other tumor types and anti-tumor agents.